{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T15:39:38Z","timestamp":1792510778393,"version":"4.5.0"},"reference-count":55,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T00:00:00Z","timestamp":1787270400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Epilepsia Open"],"published-print":{"date-parts":[[2026,10]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:label\/>\n                    <jats:p>\n                      Regulatory restrictions and evolving clinical guidelines have aimed to reduce sodium valproate use in people of reproductive potential over the past decade due to its teratogenic risk. While clinical evidence and policy responses are well established, stakeholder perspectives remain less explored. This scoping review synthesizes the existing evidence on the attitudes of patients, caregivers and healthcare professionals regarding sodium valproate use, withdrawal and counseling in females of childbearing age. This scoping review, conducted according to JBI Methodology for a Scoping Review and registered on Open Science Framework (\n                      <jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" xlink:href=\"https:\/\/doi.org\/10.17605\/OSF.IO\/HK7QN\">https:\/\/doi.org\/10.17605\/OSF.IO\/HK7QN<\/jats:ext-link>\n                      ), analyzed studies which directly reported on, or measured, the attitudes of patients, caregivers and\/or healthcare professionals regarding the use of sodium valproate for epilepsy in females. A structured search across four databases (EMBASE, Web of Science, MEDLINE, PsycINFO) and the gray literature was performed. A thematic synthesis of data was conducted to identify important themes and concepts. A total of 22 studies including 14 peer\u2010reviewed articles and 8 gray literature sources met the inclusion criteria, including only 2 qualitative studies. Most literature focused on patient and caregiver perspectives (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u200915), with fewer addressing healthcare professional views (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20097). Methodology incorporating interviews (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20092) or free\u2010text survey responses (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u20093) was uncommon. Across the studies, three key themes emerged: (i) patient disempowerment due to limited knowledge and suboptimal counseling and risk communication; (ii) the influence of maternal identity formation on attitudes, behaviors and decision\u2010making when navigating sodium valproate use; and (iii) concerns regarding regulatory responses, such as pregnancy prevention programs, particularly around implementation challenges, perceived paternalism and lack of individualized care. Published evidence on stakeholder attitudes toward sodium valproate use in people of reproductive potential remains limited. The existing literature highlights gaps in awareness, counseling, and patient\u2010centered delivery of pregnancy prevention programs. Future research should prioritize qualitative studies to better understand stakeholder attitudes and experiences to inform future guidelines and clinical practice.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Plain Language Summary<\/jats:title>\n                    <jats:p>Sodium valproate is an antiseizure medication that can harm an unborn baby when used during pregnancy. National and international programs have been introduced to reduce its use among people who could become pregnant. This review explored the perspectives of patients, caregivers and healthcare providers regarding sodium valproate use and withdrawal. Key themes included experiences of disempowerment relating to risk communication, the influence of maternal identity on treatment decisions and concerns about regulatory approaches. These findings highlight factors contributing to challenges with pregnancy prevention programs, in particular gaps in shared decision\u2010making, communication and patient\u2010centered care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/epi4.70342","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T16:04:33Z","timestamp":1787328273000},"page":"1413-1425","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Attitudes toward sodium valproate use, withdrawal, and counseling in people of reproductive potential: A scoping review"],"prefix":"10.1002","volume":"11","author":[{"given":"Katherine","family":"Wang","sequence":"first","affiliation":[{"name":"Department of Paediatrics The University of Melbourne  Parkville Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6512-8900","authenticated-orcid":false,"given":"Sarah","family":"Loveday","sequence":"additional","affiliation":[{"name":"Neurodisability and Rehabilitation Research Murdoch Children's Research Institute  Parkville Victoria Australia"},{"name":"Developmental Medicine Royal Children's Hospital  Parkville Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6589-8451","authenticated-orcid":false,"given":"Monica S.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Department of Paediatrics The University of Melbourne  Parkville Victoria Australia"},{"name":"Neurodisability and Rehabilitation Research Murdoch Children's Research Institute  Parkville Victoria Australia"},{"name":"Developmental Medicine Royal Children's Hospital  Parkville Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9894-4610","authenticated-orcid":false,"given":"Emma","family":"Macdonald\u2010Laurs","sequence":"additional","affiliation":[{"name":"Department of Paediatrics The University of Melbourne  Parkville Victoria Australia"},{"name":"Neuroscience Murdoch Children's Research Institute  Parkville Victoria Australia"},{"name":"Neurology Royal Children's Hospital  Parkville Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,8,21]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(15)00314-2"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.2165\/00023210-200822040-00004"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0907328"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000001772"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(12)70323-X"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2013.2270"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13007"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1017\/S1355617710001359"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-024-12436-8"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-020-09809-0"},{"key":"#cr-split#-e_1_2_12_12_1.1","unstructured":"OrganisationWH.Statement on the risks associated with use of valproic acid (sodium valproate) in women and girls of childbearing potential. 2023 [updated 2023 May 2"},{"key":"#cr-split#-e_1_2_12_12_1.2","unstructured":"cited 2025 Aug 10]. Available from:https:\/\/www.who.int\/news\/item\/02\u201005\u20102023\u2010use\u2010of\u2010valproic\u2010acid\u2010in\u2010women\u2010and\u2010girls\u2010of\u2010childbearing\u2010potential"},{"key":"e_1_2_12_13_1","unstructured":"AgencyEM.Summary of the EMA public hearing on valproate in pregnancy. 2017. Available from:www.ema.europa.eu"},{"key":"e_1_2_12_14_1","unstructured":"Medicines related to valproate: risk of abnormal pregnancy outcomes [Press Release]. Government United Kingdom; 2015 Jan 22."},{"key":"e_1_2_12_15_1","volume-title":"Prescribing valproate to female patients under 18\u2009years of age","year":"2024"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja2.70126"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.11124\/JBIES-20-00167"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.7326\/M18-0850"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1471-1842.2009.00848.x"},{"key":"e_1_2_12_20_1","doi-asserted-by":"crossref","unstructured":"WangK CooperMS Macdonald\u2010LaursE.Attitudes toward sodium valproate use withdrawal and counseling in females of childbearing potential: a scoping review.2025.","DOI":"10.1002\/epi4.70342"},{"key":"e_1_2_12_21_1","volume-title":"Covidence systematic review software","year":"2026"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2017.11.013"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2023.109468"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2018.01.002"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2024.110107"},{"issue":"6","key":"e_1_2_12_26_1","article-title":"Latvian healthcare professionals' self\u2010reported knowledge, attitudes, and behaviors related to pregnancy prevention program materials for valproate\u2010containing medicines","volume":"12","author":"Spoge M","year":"2024","journal-title":"Pharmacy (Basel)"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.yebeh.2019.01.037"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13211"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1177\/10398562231223082"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0000000000004893"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(18)31672-6"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1177\/0004867419834357"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1111\/epi.13043"},{"key":"e_1_2_12_34_1","first-page":"21","article-title":"Knowledge, risk perception, and reproductive decision making among women with epilepsy","volume":"8","author":"Srikanth P","year":"2023","journal-title":"Int J Epilepsy"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.seizure.2018.05.003"},{"key":"e_1_2_12_36_1","unstructured":"Fifth of women taking sodium valproate still not aware of risks. 2022. Available from:https:\/\/www.epilepsy.org.uk\/news\/almost\u2010one\u2010fifth\u2010of\u2010women\u2010taking\u2010sodium\u2010valproate\u2010for\u2010epilepsy\u2010still\u2010not\u2010aware\u2010of\u2010risks\u2010in\u2010pregnancy\u2010survey\u2010shows"},{"key":"e_1_2_12_37_1","unstructured":"Results of our valproate survey. 2020 [2025 May 01]. Available from:https:\/\/www.epilepsy.org.uk\/involved\/campaigns\/sodium\u2010valproate\/survey"},{"key":"e_1_2_12_38_1","unstructured":"MooreA.The mothers fighting a scandal bigger than thalidomide: \u2018We were told the medication was safe\u2019. 2024. Available from:https:\/\/www.theguardian.com\/society\/2024\/feb\/22\/the\u2010mothers\u2010fighting\u2010a\u2010scandal\u2010bigger\u2010than\u2010thalidomide\u2010we\u2010were\u2010told\u2010the\u2010medication\u2010was\u2010safe"},{"key":"e_1_2_12_39_1","unstructured":"SaullP.Mum's 20\u2010year fight for epilepsy drug compensation. 2025. Available from:https:\/\/www.bbc.com\/news\/articles\/cqx9nevdyldo"},{"key":"e_1_2_12_40_1","unstructured":"A \u2018long battle\u2019: Gateshead's women's fight for those impacted by sodium valproate scandal. 2025. Available from:https:\/\/www.itv.com\/news\/tyne\u2010tees\/2025\u201003\u201027\/one\u2010year\u2010on\u2010victims\u2010of\u2010valproate\u2010scandal\u2010yet\u2010to\u2010receive\u2010compensation"},{"key":"e_1_2_12_41_1","unstructured":"MayN.Epilepsy medication affected Sophie's pregnancies. Should Australia adopt tougher guidelines?https:\/\/www.theguardian.com\/lifeandstyle\/2024\/nov\/24\/sodium\u2010valproate\u2010epilepsy\u2010bipolar\u2010disorder\u2010medication\u2010risks\u2010for\u2010preganancy\u2010foi"},{"key":"e_1_2_12_42_1","unstructured":"HutchinsonS FosterA CollinsonA.Mesh and sodium valproate scandal victims need payouts soon report says. 2024. [2025 Apr 29]. Available from:https:\/\/www.bbc.com\/news\/health\u201068215937"},{"key":"e_1_2_12_43_1","unstructured":"ParasharA.The birth defect scandal bigger than thalidomide: \u2018forgotten\u2019 mothers of children left disabled by epilepsy drug taken during pregnancy fear kids will \u2018die in povery\u2019 without compensation. 2025. Available from:https:\/\/www.dailymail.co.uk\/news\/article\u201014635009\/birth\u2010defect\u2010scandal\u2010thalidomide\u2010epilepsy\u2010drug\u2010compensation.html"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1783\/147118909788708002"},{"key":"e_1_2_12_45_1","volume-title":"Recommendations from the fourth joint meeting of the WHO Advisory Committee on Safety of Medicinal Products (ACSOMP) and the WHO Global Advisory Committee on Vaccine Safety (GACVS)","author":"Organisation TWH","year":"2025"},{"issue":"8","key":"e_1_2_12_46_1","article-title":"Forbidden conversations: a comprehensive exploration of taboos in sexual and reproductive health","volume":"16","author":"Tohit NFM","year":"2024","journal-title":"Cureus"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20032215"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.wombi.2013.09.002"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjebm-2018-111068"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-023-01314-3"},{"key":"e_1_2_12_51_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m4446"},{"key":"e_1_2_12_52_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmjno-2023-000433"},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.4997\/jrcpe.2020.207"},{"key":"e_1_2_12_54_1","doi-asserted-by":"publisher","DOI":"10.1111\/ane.13231"},{"key":"e_1_2_12_55_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12884-021-04351-x"}],"container-title":["Epilepsia Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/epi4.70342","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/epi4.70342","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/epi4.70342","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:51:38Z","timestamp":1792468298000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/epi4.70342"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,21]]},"references-count":55,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["10.1002\/epi4.70342"],"URL":"https:\/\/doi.org\/10.1002\/epi4.70342","archive":["Portico"],"relation":{},"ISSN":["2470-9239","2470-9239"],"issn-type":[{"value":"2470-9239","type":"print"},{"value":"2470-9239","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,21]]},"assertion":[{"value":"2026-04-24","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-09","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-21","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}